149 related articles for article (PubMed ID: 26946078)
21. Overexpression of Rac1 in leukemia patients and its role in leukemia cell migration and growth.
Wang J; Rao Q; Wang M; Wei H; Xing H; Liu H; Wang Y; Tang K; Peng L; Tian Z; Wang J
Biochem Biophys Res Commun; 2009 Sep; 386(4):769-74. PubMed ID: 19563775
[TBL] [Abstract][Full Text] [Related]
22. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
23. Physical biomarkers for human hematopoietic stem and progenitor cells.
Tanaka M; Thoma J; Poisa-Beiro L; Wuchter P; Eckstein V; Dietrich S; Pabst C; Müller-Tidow C; Ohta T; Ho AD
Cells Dev; 2023 Jun; 174():203845. PubMed ID: 37116713
[TBL] [Abstract][Full Text] [Related]
24. Coexpression of hyperactivated AKT1 with additional genes activated in leukemia drives hematopoietic progenitor cells to cell cycle block and apoptosis.
Tang Y; Halvarsson C; Nordigården A; Kumar K; Åhsberg J; Rörby E; Wong WM; Jönsson JI
Exp Hematol; 2015 Jul; 43(7):554-64. PubMed ID: 25931014
[TBL] [Abstract][Full Text] [Related]
25. Osteogenic niche in the regulation of normal hematopoiesis and leukemogenesis.
Le PM; Andreeff M; Battula VL
Haematologica; 2018 Dec; 103(12):1945-1955. PubMed ID: 30337364
[TBL] [Abstract][Full Text] [Related]
26. Function of Jam-B/Jam-C interaction in homing and mobilization of human and mouse hematopoietic stem and progenitor cells.
Arcangeli ML; Bardin F; Frontera V; Bidaut G; Obrados E; Adams RH; Chabannon C; Aurrand-Lions M
Stem Cells; 2014 Apr; 32(4):1043-54. PubMed ID: 24357068
[TBL] [Abstract][Full Text] [Related]
27. Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance.
Hoang VT; Zepeda-Moreno A; Ho AD
Biotechnol J; 2012 Jun; 7(6):779-88. PubMed ID: 22588704
[TBL] [Abstract][Full Text] [Related]
28. Loss of EfnB1 in the osteogenic lineage compromises their capacity to support hematopoietic stem/progenitor cell maintenance.
Arthur A; Nguyen TM; Paton S; Zannettino ACW; Gronthos S
Exp Hematol; 2019 Jan; 69():43-53. PubMed ID: 30326247
[TBL] [Abstract][Full Text] [Related]
29. Extracellular vesicles impose quiescence on residual hematopoietic stem cells in the leukemic niche.
Abdelhamed S; Butler JT; Doron B; Halse A; Nemecek E; Wilmarth PA; Marks DL; Chang BH; Horton T; Kurre P
EMBO Rep; 2019 Jul; 20(7):e47546. PubMed ID: 31267709
[TBL] [Abstract][Full Text] [Related]
30. Transformation of Hematopoietic Stem and Progenitor Cells by Leukemia Extracellular Vesicles: A Step Toward Leukemogenesis.
Samii A; Razmkhah F
Stem Cell Rev Rep; 2020 Dec; 16(6):1081-1091. PubMed ID: 32500481
[TBL] [Abstract][Full Text] [Related]
31. Rho GTPases and regulation of hematopoietic stem cell localization.
Williams DA; Zheng Y; Cancelas JA
Methods Enzymol; 2008; 439():365-93. PubMed ID: 18374178
[TBL] [Abstract][Full Text] [Related]
32. IGF binding protein 2 is a cell-autonomous factor supporting survival and migration of acute leukemia cells.
Chen X; Zheng J; Zou Y; Song C; Hu X; Zhang CC
J Hematol Oncol; 2013 Oct; 6(1):72. PubMed ID: 24191913
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs and Metabolites in Serum Change after Chemotherapy: Impact on Hematopoietic Stem and Progenitor Cells.
Walenda T; Diener Y; Jost E; Morin-Kensicki E; Goecke TW; Bosio A; Rath B; Brümmendorf TH; Bissels U; Wagner W
PLoS One; 2015; 10(5):e0128231. PubMed ID: 26024523
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts.
Krevvata M; Silva BC; Manavalan JS; Galan-Diez M; Kode A; Matthews BG; Park D; Zhang CA; Galili N; Nickolas TL; Dempster DW; Dougall W; Teruya-Feldstein J; Economides AN; Kalajzic I; Raza A; Berman E; Mukherjee S; Bhagat G; Kousteni S
Blood; 2014 Oct; 124(18):2834-46. PubMed ID: 25139351
[TBL] [Abstract][Full Text] [Related]
35. The efficacy of the ribonucleotide reductase inhibitor Didox in preclinical models of AML.
Cook GJ; Caudell DL; Elford HL; Pardee TS
PLoS One; 2014; 9(11):e112619. PubMed ID: 25402485
[TBL] [Abstract][Full Text] [Related]
36. Role of Microenvironment in Resistance to Therapy in AML.
Tabe Y; Konopleva M
Curr Hematol Malig Rep; 2015 Jun; 10(2):96-103. PubMed ID: 25921386
[TBL] [Abstract][Full Text] [Related]
37. Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow.
Adamiak M; Borkowska S; Wysoczynski M; Suszynska M; Kucia M; Rokosh G; Abdel-Latif A; Ratajczak J; Ratajczak MZ
Oncotarget; 2015 Aug; 6(22):18819-28. PubMed ID: 26299919
[TBL] [Abstract][Full Text] [Related]
38. Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases.
Gu Y; Filippi MD; Cancelas JA; Siefring JE; Williams EP; Jasti AC; Harris CE; Lee AW; Prabhakar R; Atkinson SJ; Kwiatkowski DJ; Williams DA
Science; 2003 Oct; 302(5644):445-9. PubMed ID: 14564009
[TBL] [Abstract][Full Text] [Related]
39. Acute exercise mobilizes hematopoietic stem and progenitor cells and alters the mesenchymal stromal cell secretome.
Emmons R; Niemiro GM; Owolabi O; De Lisio M
J Appl Physiol (1985); 2016 Mar; 120(6):624-32. PubMed ID: 26744505
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia niche.
Chen DW; Fan JM; Schrey JM; Mitchell DV; Jung SK; Hurwitz SN; Perez EB; Muraro MJ; Carroll M; Taylor DM; Kurre P
Leukemia; 2024 Apr; 38(4):741-750. PubMed ID: 38228679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
